Egetis Therapeutics — Major Shareholding Notification 2020

Jun 27, 2020

Issuer Egetis Therapeutics AB (publ)

Holder

nortal investments AB

Instrument

Instrument	Aktier SE0003815604
Before the transaction
Shares	11,168,591
Voting rights	11,168,591
Transaction
Reason for major shareholding notification Sell
Date	26/06/2020
Limit for number of shares	15 %
Limit for number of votes	15 %
After the transaction
Quantity
Shares	7,168,591
Directly held voting rights	7,168,591
Indirectly held voting rights	7,168,591
Percentage
Directly held shares	13 %
Directly held voting rights	13 %
Indirectly held voting rights	0 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	13 %	7,168,591
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled - Cash settled
Total	13 %	7,168,591
Group total holdings
Voting rights 7,168,591 Percentage of voting rights 13
Published 27/06/2020 10:20
Contact
Name staffan persson
Phone 0703210098	Email sp@swediacapital.se
CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25